Back to search

Institutional Repository of Vilnius University

Insights into type III CRISPR-Cas immunity: mechanisms of Csm6 deactivation and a comprehensive characterization of the Lon-SAVED effector /

Abstract

dc:description

Bacteria and archaea use CRISPR-Cas systems to defend themselves against viral infection. These adaptive immune mechanisms detect and neutralize invading nucleic acids. Among them, type III CRISPR-Cas systems are unique: alongside viral RNA degradation, they trigger an additional layer of defense by producing signaling molecules, cyclic oligoadenylates (cAn), which activate various downstream effectors. This thesis explores two of these effectors: the ribonuclease Csm6 and a Lon-SAVED fusion protein CalpL of the tripartite CalpL-CalpT-CalpS effector. Csm6 is activated by cA6 binding to its CARF domain, triggering HEPN domain-mediated RNA degradation. Cell metabolite analysis and biochemical assays revealed that Csm6 also degrades its own activator, cA6, creating a built-in self-limiting loop. The second part characterizes the CalpL-CalpT-CalpS effector, which responds to cA4. Biochemical and in vivo toxicity assays showed that cA4 binding activates CalpL to cleave the anti-σ factor CalpT, marking it for degradation by cellular proteases and thereby releasing the σ factor CalpS. CalpL also degrades its own activator, functioning as a self-limiting effector. Furthermore, structural studies revealed how filament formation governs CalpL’s protease and the regulatory ring nuclease activities. Together, these findings show how type III effectors integrate cAn signaling with intrinsic regulatory mechanisms.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Smalakytė, Dalia,

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Smalakytė, Dalia,. Insights into type III CRISPR-Cas immunity: mechanisms of Csm6 deactivation and a comprehensive characterization of the Lon-SAVED effector /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD238796892&prefLang=en_US